Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the role telemedicine can play in cancer treatment.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the effectiveness of liquid biopsies at detecting TKI resistance for fusions such as ALK, ROS1, and RET.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss whether there is a case for testing both pleural fluid and blood biopsy.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the coverage, cost, and standard of care for liquid and tissue biopsy monitoring.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss whether circulating tumor DNA testing will replace marker testing.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss which tests are relevant for which diagnoses in lung cancer.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the usage of liquid and tissue biopsies in patients with acquired resistance.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss anxiety and symptom burden, and balancing the wait for biopsy results vs. starting treatment.

Doctors Jared Weiss, Ibiayi Dagogo-Jack, and Jeffrey Thompson discuss the challenges and uses of liquid and tissue biopsies in patients with acquired resistance.

Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma.
Dr. Meredith McKean discusses molecular profiling and driver mutations in patients with melanoma.
A huge thank you to our sponsors #Merck and #Exelixis!

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.